USANA HEALTH SCIENCES INC
For the period ended Oct 9, 2025. Filed Oct 9, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 9, 2025 · Filed Oct 9, 2025
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 27, 2025 | September 28, 2024 | September 27, 2025 | September 28, 2024 | |
| Net (loss) earnings attributable to USANA (GAAP) | $ (6,522) | $ 10,607 | $ 12,535 | $ 37,576 |
| Earnings (loss) per common share - Diluted (GAAP) | $ (0.36) | $ 0.56 | $ 0.67 | $ 1.96 |
| Weighted average common shares outstanding - Diluted | 18,293 | 19,083 | 18,671 | 19,181 |
| Adjustment to net (loss) earnings: | ||||
| Transaction, integration and transition costs - Hiya | $ 179 | $ - | $ 871 | $ - |
| Inventory step-up - Hiya | - | - | 1,126 | - |
| Amortization of intangible assets - Hiya | 4,455 | - | 13,366 | - |
| Adjustments to net (loss) earnings attributable to noncontrolling interest | (941) | - | (3,066) | - |
| Income tax effect of adjustments to net (loss) earnings | - | - | (4) | - |
| Adjusted net (loss) earnings attributable to USANA | $ (2,829) | $ 10,607 | $ 24,828 | $ 37,576 |
| Adjusted (loss) earnings per common share - Diluted | $ (0.15) | $ 0.56 | $ 1.33 | $ 1.96 |
| Weighted average common shares outstanding - Diluted | 18,293 | 19,083 | 18,671 | 19,181 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.